October 24/Boston/Reuters -- A Harvard-affiliated hospital is backing away from its decision earlier this week to promote a paper linking the artificial sweetener aspartame and cancer, now saying the evidence was "weak."
Brigham and Women's Hospital said in an email to reporters that data in the paper, which was published in the Journal of Clinical Nutrition, "is weak, and that Brigham and Women's Hospital media relations was premature in the promotion of this work."